Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Silberberg

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Annals of Neurology|January 1, 1982
In vivo demyelinating activity of sera from patients with Guillain-Barré syndromeT Saida, K Saida, R P Lisak, et al.
Neuroscience Letters|April 1, 1980
Antisera to bovine oligodendroglia raised in guinea pigs bind to surface of rat oligodendroglia and Schwann cellsR P Lisak, R M Pruss, P G Kennedy, et al.
Transactions of the American Neurological Association|January 1, 1981
Human fetal alpha-fetoprotein fractions inhibit antibody-mediated lysis of oligodendrocytes in vitroI Lubetzki-Korn, D H Silberberg, M Hirayama, et al.
Annals of Neurology|March 1, 1992
Revised estimate of the prevalence of multiple sclerosis in the United StatesD W Anderson, J H Ellenberg, C M Leventhal, et al.
Annals of Neurology|September 1, 1987
Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disordersA M Rostami, J B Burns, P A Eccleston, et al.
Science (New York, N.Y.)|July 19, 1991
Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramideJ M Harouse, S Bhat, S L Spitalnik, et al.
Microbial Pathogenesis|August 1, 1987
Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell culturesE Lavi, A Suzumura, M Hirayama, et al.
Brain Research|December 19, 1983
Cultured human and rat oligodendrocytes and rat Schwann cells do not have immune response gene associated antigen (Ia) on their surfaceR P Lisak, M Hirayama, D Kuchmy, et al.
Radiology|October 1, 1988
Multiple sclerosis: serial study of gadolinium-enhanced MR imagingR I Grossman, B H Braffman, J R Brorson, et al.
Neurology|September 1, 1979
The design of clinical studies to assess therapeutic efficacy in multiple sclerosisJ R Brown, G W Beebe, J F Kurtzke, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Annals of Neurology|January 1, 1982
In vivo demyelinating activity of sera from patients with Guillain-Barré syndromeT Saida, K Saida, R P Lisak, et al.
Neuroscience Letters|April 1, 1980
Antisera to bovine oligodendroglia raised in guinea pigs bind to surface of rat oligodendroglia and Schwann cellsR P Lisak, R M Pruss, P G Kennedy, et al.
Transactions of the American Neurological Association|January 1, 1981
Human fetal alpha-fetoprotein fractions inhibit antibody-mediated lysis of oligodendrocytes in vitroI Lubetzki-Korn, D H Silberberg, M Hirayama, et al.
Annals of Neurology|March 1, 1992
Revised estimate of the prevalence of multiple sclerosis in the United StatesD W Anderson, J H Ellenberg, C M Leventhal, et al.
Annals of Neurology|September 1, 1987
Search for antibodies to galactocerebroside in the serum and cerebrospinal fluid in human demyelinating disordersA M Rostami, J B Burns, P A Eccleston, et al.
Science (New York, N.Y.)|July 19, 1991
Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramideJ M Harouse, S Bhat, S L Spitalnik, et al.
Microbial Pathogenesis|August 1, 1987
Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell culturesE Lavi, A Suzumura, M Hirayama, et al.
Brain Research|December 19, 1983
Cultured human and rat oligodendrocytes and rat Schwann cells do not have immune response gene associated antigen (Ia) on their surfaceR P Lisak, M Hirayama, D Kuchmy, et al.
Radiology|October 1, 1988
Multiple sclerosis: serial study of gadolinium-enhanced MR imagingR I Grossman, B H Braffman, J R Brorson, et al.
Neurology|September 1, 1979
The design of clinical studies to assess therapeutic efficacy in multiple sclerosisJ R Brown, G W Beebe, J F Kurtzke, et al.
Pageof 10